Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
Sign Up to like & getrecommendations! Published in 2018 at "Vaccine"
DOI: 10.1016/j.vaccine.2018.02.034
Abstract: BACKGROUND The Food and Drug Administration (FDA) approved quadrivalent human papillomavirus vaccine (4vHPV) for use in females and males aged 9-26 years, since 2006 and 2009 respectively. We characterized reports to the Vaccine Adverse Event Reporting… read more here.
Keywords: quadrivalent human; vaccine; safety; reporting system ... See more keywords
Immunogenicity of a quadrivalent human papillomavirus vaccine in pediatric kidney and liver transplant recipients
Sign Up to like & getrecommendations! Published in 2023 at "Pediatric Transplantation"
DOI: 10.1111/petr.14476
Abstract: Solid‐organ transplant recipients are at increased risk of developing human papillomavirus‐related diseases. read more here.
Keywords: transplant recipients; papillomavirus vaccine; quadrivalent human; human papillomavirus ... See more keywords